Alterations in the cellular DNA and protein content determined by flow cytometry as indicators for chemically induced structural and numerical chromosome aberrations by Maier, Peter & Schawalder, Hanspeter
Mutagenesis vol.3 no.3 pp.219-226, 1988
Alterations in the cellular DNA and protein content determined by
flow cytometry as indicators for chemically induced structural and
numerical chromosome aberrations
Peter Maier and Hanspeter Schawalder
Institute of Toxicology, Swiss Federal Institute of Technology and
University of Zurich, CH-8603 Schwerzenbach, Switzerland
Cellular DNA and protein content were determined simul-
taneously in freshly isolated fibroblast-like rat cells by flow
cytometry. After exposure to doxorubicin, nitrofurantoin,
propranolol and practolol at a low, tissue like oxygen con-
centration (5% O2), drug-induced alterations in cell cycle
kinetics, in the distribution of DNA and in the protein con-
tent of G,-phase cells (nucleus/cytoplasm ratio) were analys-
ed. Optimal exposure time (5 or 24 h) and recovery interval
(24 or 48 h) were determined. Variation in the exposure time
and recovery period can affect cell cycle kinetics both quali-
tatively and quantitatively, whereas the distribution of DNA
and protein content are affected quantitatively only. A 24-h
exposure combined with a 24-h recovery period proved to be
the most efficient approach. Each of the tested chemicals in-
duced a specific, dose-dependent pattern of altered cellular
DNA and protein content. Comparison with results obtained
in other genotoxicity tests, and with data reported earlier,
showed that this two-parameter protocol can be used to recog-
nize and to characterize chemicals as clastogens, or as com-
pounds with a combined cytostatic/clastogenic activity, or as
spindle-poison-like compounds.
Introduction
In a given cell population, flow cytometry provides an efficient
tool to analyse specific constituents of individual cells. By
simultaneous analysis of the DNA and protein content of intact
cells by two-parameter flow cytometry (Maier and Schawalder,
1986) relationships between the cytotoxic/cytostatic activities and
the genotoxic activity following exposure to mutagens can be
defined. Indicators of such activities are blockage at a specific
cell cycle phase, alterations in the dispersion of cellular DNA
and protein content in G|-phase cells and an imbalance between
the two parameters (nucleus/cytoplasm ratio). Using this proto-
col, surviving intact cells are analysed and drug-induced dead
cells, with lysed or fragmented nuclei, can readily be discrim-
inated.
During metaphase analysis, only those cells which terminate
DNA synthesis and G2 phase during the relative short arrest
interval are analysed. In contrast, using flow cytometry, cells
in all cycle phases can be analysed. Analysis of Grphase cells
allows chemicals with an S-phase dependent activity to be
recovered when a sufficient number of damaged cells enter the
G| phase following treatment. This post-mitotic analysis might
be advantageous, particularly for the detection of spindle poisons
which induce numerical chromosome aberrations.
With the extension of the recovery period, the accumulation
of aneuploid, often slowly cycling cells in the G, phase, might
be increased. Alternatively, selection against these abnormal cells
occurs as a function of the proliferative activity of the normal
cells (cell density).
Therefore, the objective of the present study was (i) to evaluate
further the suitability of the two-parameter flow cytometry pro-
tocol established in this laboratory (Maier and Schawalder, 1986)
by varying exposure and recovery periods and (ii) to use this
system to analyse two 'problematic' chemicals: nitrofurantoin
and propranolol.
The anthracycline antibiotic doxorubicin (DX) was used as a
positive control. This chemical is a powerful clastogen in vitro
(Vig, 1977), in vivo in mice (Maier and Schmid, 1976; Au and
Hsu, 1980) and man (Hacker-Klom et al., 1986). The drug is
highly fluorescent (Krishan and Ganapathi, 1980), and when ex-
cited with a 350-nm argon laser beam, the emission spectrum
(Krishan et al., 1985) is in the same range as the DNA
fluorochrome (DAPI) used in the present investigation. This prop-
erty provided an opportunity to investigate whether the drug could
interfere with analysis of DNA.
Nitrofurantoin (NF) is an antibacterial agent used in human
and veterinary medicine for the treatment of systemic infections
specifically of the urinary tract. It is highly mutagenic in bacterial
test systems (Cohen et al., 1973; Yahagi et al., 1976) and induces
mitotic gene conversion in yeast (Siebert et al., 1979). However,
in mammalian cells, the drug causes only a low incidence of sister
chromatid exchanges (Shirai and Wang, 1980). No tumorigenic
activity has so far been reported in rodents (Morris et al., 1969;
Yahagi et al., 1974). This discrepancy between the mutagenic
and carcinogenic activity and the pathways involved in drug
activation in mammalian tissues is still a matter for debate
(McCalla, 1983). In particular, it is not clear whether the
reactivity of the chemical is influenced by the oxygen tension
present in tissues.
The third chemical tested was propranolol, a /3-adrenergic
blocking agent with widespread use in the treatment of
hypertension in man. This compound was reported positive in
the micronucleus test (Okine et al., 1983; Aruna and Krishna-
murthy, 1986) but its genotoxicity has not been confirmed in other
assays. Practolol is also a /3-blocking agent which has been
withdrawn from the market because of its induction of a rare
oculomucocutaneous syndrome (Wright, 1975) in humans. It was
used as a negative control.
Primary cultures of fibroblast-like rat cells were used in the
experiments. These euploid cells maintain a highly stable DNA
content over several passages and their metabolism parallels that
found in the corresponding tissue in vivo.
Materials and methods
Chemicals
The source of the chemicals was as follows: DX (Farmitalia, Carlo Erba, Milano,
Italy), NF (l-[(5-nitrofurfurylidene) amino]-hydantoin) (Sigma Chemical Company,
St Louis, MO, USA), practolol [M4-(2-hydroxy)-3(l-metyl)-aminopropoxyphenyl-
acetamine] and propranolol [l-(isopropylamino)-3(l-naphthyI-oxy)-2-propranolol]
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Fig. 1. Influence of exposure/recovery schedule on DNA/protein parameters in untreated cells. Data are pooled from control values of all chemicals tested.
The culture period corresponds to the following exposure/recovery periods: 48 h = 24/0 h; 53 h = 5/24 h; 72 h = 24/24 h; 96 h = 24/48 h.
(Imperial Chemical Industries, Macclesfield, UK). DX, practolol and propranolol
were dissolved in culture media (Dulbecco's modified Eagle's medium, DMEM)
and NF in dimethylsulphoxide (DMSO) to a maximal final concentration of 0.3%
at the highest exposure level. Appropriate controls were carried out with the highest
DMSO concentration. The fluorochromes used were sulphorhodamine 101 (SR
101, Sigma) for protein 4,6-diamidino-2-phenyl indole dihydrochloride (DAPI,
Serva, Munich, FRG) for DNA.
Cells and treatment
Fibroblast-like cells were isolated from subcutaneous granulation tissue of nearly
adult male rats (220 ± 15 g, n = 15, Sprague-Dawley, SIV 50, Ivanovas,
Kisslegg, FRG). Growth of this tissue was initiated on the inside wall of an air
pouch at the scapular region of young adult male rats (Maier, 1984). Four days
later, cells were isolated according to standardized procedures. Fibroblast-like
cells were then cultured for 3 days in DMEM supplemented with 10% fetal calf
serum and 5 /jl/ml gentamycin under the following conditions: 12% CO2, 5%
O2, 36.5°C, pH 7.4, RH 95%. Exposure of cells occurred at physiologic tissue
pO2 which corresponds to an O2 concentration in the incubator of 5 % (Maier
et al., 1987). In a series of experiments with NF, hyperoxic conditions (31%
O2) were chosen.
On day 3, cells were trypsinized and the cells seeded per dish were adapted
according to the exposure/recovery period in order to prevent contact inhibition
of growth. After 24 h in culture, the test compounds were added for 5 or 24 h
to these asynchronous, rapidly proliferating cell populations. The short exposure
time (5 h) was assumed to approximate to the exposure time which would be
expected after an in vivo treatment. The 24-h exposure interval covers more than
the whole cell cycle of proliferating cells.
After replacement of the medium, treated cells were subjected to a recovery
period of 24 or 48 h. The extended recovery period was designed to increase
further the accumulation of aneuploid cells in G, phase. Subsequently, cultures
were washed with phosphate-buffered saline (PBS), trypsinized (trypsin/EDTA)
and the dispersed cells fixed in cold 70% ethanol added to the culture dishes.
After centrifugation cells were fixed in 90% ethanol for 30 min to 2 h.
Staining
The staining solution was a mixture of 10 ml SR 101 solution (3 mg
sulphorhodamine 101 dissolved in 100 ml Tris-HCl, 180 mM, pH 7.4, 200
mM NaCl) and 0.3 ml DAPI solution (10 mg DAPI in Tris-HCl) as described
earlier (Stohr et al., 1978; Maier and Schawalder, 1986). This cold staining solution
was added to the cell pellet. Cells were suspended and stained for 15 min on
a Coulter Mixer in the dark. Subsequently, they were stored on ice (1 —2 h) and
filtered through a 14-/un nylon mesh immediately before flow analysis.
Flow measurements
Stained samples were analysed in the staining solution on a PAS n flow cytometer
(Partec, Arlesheim, Switzerland) with the following conditions: excitation—I00-W
mercury lamp, UG1 (290-410 nm. 3 mm), chromatic beam splitter (460 nm);
emission—beam splitter (610 nm), 610-nm barrier filter for SR 101 analysis and
a GG 455 filter for DAPI signals. Flow rate: 200-400 cells/s; objective: 40 x
Nikon UV-F for epifluorescence (numerical aperture 1.3) with glycerine immersion
and KoWer illumination. As an internal standard for DNA we took freshly isolated
and fixed rat thymocytes. Their coefficients of variation (CV) in the DNA content
of G| cells before measurements were always <2.5%. Standards for protein
were cryopreserved fibroblast-like human cells. Protein measurements were
triggered by the DNA fluorescence signals.
From each treated cell population, 5 x 104 cells were analysed. Each chemical
was tested in one experiment over the whole dose range including the control
Measurements were repeated in 3 - 5 separate experiments (Table HI)- The controls
were rerun after each individual series. Only when the same modal DNA values
were obtained as at the beginning were data further analysed.
Data acquisition was carried out with a FDAS II computer (Ahrens et al., 1980).
From each sample the single-parameter frequency distribution histograms of DNA
and protein, the two-parameter contour display, the three-dimensional perspective
display and the protein single-parameter histogram of gated G, cells were
recorded and stored on floppy disks.
Data analysis
DNA and protein single-parameter histograms were analysed with fitting programs
(FIT 4.24) provided by O.Ahrens (Bargteheide, FRG). The DNA dispersion of
the G| peak was described by the coefficient of variation of the G| cell population
(CVG|). The relative contribution of cells in the G|/Go, S and G2/M phases was
calculated by means of a modified least-square fitting method (Gray and Dean,
1980) (Figure 2b).
The values of the cellular protein content in gated G, cells were best fitted
by a .Y-log-normal distribution (Figure 2c). The channel position of the modus
(CPG|) and the width of the distribution (WG| value) were used to describe the
drug-induced effects. An excellent correlation existed between the position of
the modus of the protein distribution and the protein content of these cells as
determined by the method of Bradford (1976) (data not shown).
DNA and protein data are summarized in Tables I, II and III. Values represent
the mean from individual experiments, including standard deviations.
For illustration, the dose - response effect of DX is shown in representative
single-parameter DNA and protein histograms with the corresponding contour
plots (Figure 2). Histograms selected best fit the mean value at this exposure
levels as indicated in Table III. They are representative for the analysis of the
other chemicals.
Results
From untreated cell populations, the mean of the CV of the DNA
content in G, cells ranged from 2.7 to 4.9% between individual
independent experiments. This variability may be due to
differences in cell preparations (fixation), in the staining solutions
and most importantly on the condition of the high-pressure
mercury arc lamp or in the adjustments of the optical system of
the flow cytometer. CV values respond most sensitively to these
parameters. Therefore, only when experiments are performed
over the entire dose range of a chemical, in the cell population
from the same rat, analysed on the same day and with reference
samples always used after each abnormal histogram, will drug-
induced CV alterations be discriminated from artefacts.
Alterations in the cell cycle kinetics of untreated cells might
arise from handling of the cells during culture. This was demon-
strated by the analysis of six untreated cell populations cultured
in parallel from two animals (Table I). Clearly, growth behaviour
from one culture dish to the other from the same animal does
not significantly contribute to the observed variations. The
variability derives from the use of cell populations from different
rats.
Alterations in cell cycle phases of untreated cells were also
found with increasing culture time in the protocols chosen (Table
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Fig. 2. Analysis of cellular DNA and protein content, (a) Gate for protein analysis in G, cells defined in the contour plots, (b) Analysis of DNA parameters
[coefficient of variation of Grphase cells (CVGI) and G r , S- and G2-phase calculations] from the DNA histogram, (c) Analysis of protein histograms of G,
cells: channel position (CPG|) and W value (WG|) and drug induced effects by doxorubicin.
HI). This was due to the decrease of the trypsin-induced
synchronization after subcloning and, despite the reduction of
cell number in the 24/24- and 24/48-h schedules, to a density-de-
pendent inhibition of growth. The altered growth rate alone does
not affect CV, CP and W values as shown in Figure 1. Accord-
ingly a chemical which affects growth behaviour alone will not
affect these parameters. At the time of treatment, however (24
h after seeding), these differences between the protocols do not
exist.
In untreated cell populations, the positions of the mode of the
protein histograms (CPG1) in relation to the cellular standard
(cryopreserved fibroblast-like human cells) do not vary more than
± 5 %. The W values as an indicator for the heterogeneity in the
protein histograms varied between 1.32 and 1.47.
Exposure levels were selected so that no signs of acute (detach-
ment of cells) or delayed toxicity (protein leakage) within the
24-h or the 48-h recovery period were observed. Extension of
the exposure period enhanced the dose-dependent increase of the
dispersion of DNA content (CVG, values) by DX and NF. This
is probably due to the fact that more cells were dividing in the
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Table I. DNA and protein parameters determined from histograms of untreated cells cultured in parallel
Rat 1
Mean ±SD
Rat 2
Mean ±SD
Culture no.
1
2
3
4
5
6
1
2
3
4
5
6
DNA
(contribution in %
48.3
46.6
43.4
46.0
44.8
45.3
45.7 ± 1.7
52.7
53.5
52.2
48.4
52.1
48.4
51.3 ± 2.1
)
S
30.4
31.0
32.5
30.0
33.0
31.8
31.5 ± 1.2
25.8
24.7
25.3
25.0
26.1
27.3
25.7 ± 0.9
G2
21.2
22.5
24.1
24.0
22.3
22.9
22.8 ± 1.1
21.6
21.8
22.6
26.2
21.8
24.3
23.1 ±1.8
cvcl
4.7
5.6
4.6
4.5
4.8
5.1
4.9 ± 0.4
3.1
4.8
4.2
4.5
4.0
4.9
4.3 ± 0.7
Protein
CPG,
67
80
75
77
77
71
75 ± 5
79
68
83
82
70
70
75 ± 7
wG,
1.46
1.42
1.40
1.40
1.40
1.42
1.41 ± 0.03
1.35
1.37
1.40
1.40
1.38
1.40
1.38 ± 0.02
Data are obtained with cells from two rats. Six dishes were cultured in parallel and analysed individually 48 h after seeding.
Table II. Influence on DNA and protein parameters as a function of cell density and conformational changes of G^phase cells to G0-phase cells
Culture
48-h
72-h
96-h
DNA
(contribution in %
G,
48.4 ± 1.1
63.3 ± 7.7
81.7 ± 4.5
•)
S
27.0
20.2
6.7
±
±
+
0.7
5.7
1.2
G2
24.6
16.6
11.7
±
±
+
0.4
2.0
3.3
cvG1
3.9 ±
3.3 ±
3.2 ±
1.4
1.0
0.4
cv G 2
4.3 ±
3.6 ±
3.5 ±
1.6
1.3
0.4
Protein
CPGI
68 ± 1
70 ± 3
69 ± 15
1.42
1.37
1.45
±
±
±
0.06
0.03
0.16
Values are from four independent continuous cultures analysed 48, 72 and 96 h after seeding of 3 x 105 cells into 15-cm dishes. Values = mean ± SD.
Table ID. DNA and protein parameters calculated from single-parameter histograms of cells exposed to test compounds
Exposure
Doxorubicin
Control
0.002 iiM
0.01 jiM
0.02 fiM
0.1 fiM
0.2 (iM
Nitrofurantoin
Control
5% O2
Treatment
interval
(h)
5
24
24
5
24
24
5
24
24
5
24
24
5
24
24-
5
24
24
5
24
24
24
Recovery
period
(h)
24
24
48
24
24
48
24
24
48
24
24
48
24
24
48
24
24
48
24
0
24
48
n
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
4
4
DNA
(contribution in %
G,
48.7 ± 3.2
59.6 ± 8.3
70.8 ± 14.0
45.4 ± 3.2
54.0 ± 3.0
70.7 ±11.5
48.0 ± 3.7
56.4 ± 1.4
69.0 ± 10.6
47.2 ± 1.7
59.0 ± 4.4
68.6 ± 10.6
54.9 ± 2.2*
54.8 ± 4.4
60.7 ± 2.5
48.0 ± 5.2
48.9 ± 4.6
51.6 ± 0.5
70.8 ± 22.2
49.3 ± 1.5
58.7 ± 2.6
72.8 ± 9.6
)
S
28.9
22.1
11.3
28.0
24.6
11.6
28.3
22.5
12.3
26.7
18.3
11.8
20.5
10.8
8.2
19.7
11.9
11.5
17.3
32.1
25.5
15.3
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
1.5
5.2
8.0
5.9
0.4
8.5
2.7
0.3
5.7
1.2*
1.7
5.3
3.5*
2.0*
1.8
2.3*
2.9
3.2
16.1
3.2
1.9
5.5
G2
22.4
18.3
17.6
26.6
21.4
17.8
23.7
21.1
18.8
26.1
22.7
19.6
24.5
34.4
31.1
32.3
39.1
36.9
12.0
18.8
15.8
11.9
±
±
±
±
±
±
±
t
t
t
t
2.1
3.3
6.7
2.8
2.8*
3.9
1.3
1.7*
4.9
0.5
4.0*
5.6
2.5
2.4*
1.0*
7.2
2.1*
2.8*
6.2
1.6
1.2
4.3
cvG,
4.2 ± 1.1
3.5 ± 0.8
4.9 ± 1.4
4.0 ± 1.0
5.0 ± 0.2
5.4 ± 1.0
4.9 ± 0.3
5.3 ± 1.1*
6.8 ± 2.1
6.1 ± 1.3
5.1 ± 2.0
6.1 ± 0.9
5.9 ±
7.7 ±
8.1 ±
7.6 ±
8.3 ±
9.4 ±
.6
.8*
.8*
.4
.2*
.8*
3.4 ± 0.8
2.6 ± 0.5
3.3 ± 1.3
2.7 ± 0.5
Protein
CPG,
66 ± 4
70 ± 2
62 ± 4
76 ± 9*
65 ± 14
59 ± 10
71 ± 15
71 ± 5
75 ± 8*
68 ± 15
78 ± 8
68 ± 12
82 ± 23
107 ± 14*
98 ± 7*
84 ± 23
116 ± 30*
112 ± 13*
70 ± 1
65 ± 2
67 ± 14
78 ± 9
w o ,
1.44 ±
1.36 ±
1.47 ±
1.42 ±
1.42 ±
1.45 ±
1.40 ±
1.46 ±
1.53 ±
1.45 ±
1.56 ±
1.57 ±
1.54 ±
1.88 ±
1.93 ±
1.59 ±
1.93 ±
2.08 ±
1.32 ±
1.41 ±
1.36 ±
1.39 ±
0.05
0.3
0.08
0.01
0.04
0.05
0.08
0.06
0.09
0.04
0.05*
0.15
0.09*
0.13*
0.15*
0.12*
0.04*
0.38*
0.01
0.03
0.06
0.08
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Exposure
31% O,
20 fiM
5% 0 ,
31% O,
40 iiM
5% O,
31% 0 ,
100 tiM
5% O2
31% *2
200
 MM-
5% O,
31% O2
Propranolol
Control
2
10 iiM
32 (iM
100 (iM
Treatment
interval
(h)
24
24
24
5
24
24
24
24
24
24
5
24
24
24
24
24
24
24
24
24
24
24
24
5
24
24
24
24
24
24
5
24
5
24
5
24
5
24
5
24
Recovery
period
(h)
0
24
48
24
0
24
48
0
24
48
24
0
24
48
0
24
48
0
24
48
0
24
48
24
0
24
48
0
24
48
24
24
24
24
24
24
24
24
24
24
n
2
4
3
1
2
4
2
2
4
2
2
2
4
4
2
4
3
2
4
4
2
5
3
2
2
4
4
2
4
2
3
4
3
4
3
4
2
2
3
4
DNA
(contribution in 7t)
G,
67.0 ±
54.6 ±
56.7 ±
56.8
53.0 ±
59.5 ±
60.6 ±
71.4 ±
54.0 ±
49.1 ±
68.9 ±
53.3 ±
57.5 ±
67.6 ±
65.3 ±
57.6 ±
53.0 ±
59.8 ±
62.9 ±
58.3 ±
69.5 ±
55.7 ±
46.6 ±
70.1 ±
55.3 ±
61.0 ±
53.3 ±
60.8 ±
63.4 ±
43.3 ±
49.7 ±
56.9 ±
48.5 ±
55.9 ±
49.5 ±
55.4 ±
46.0 ±
51.3 ±
46.6 ±
53.5 ±
9.6
3.5
8.3
4.0
4.3
5.6
14.8
8.7
6.3
18.0
2.3
4.9
10.3*
20.5
9.4
14.6
23.9
9.4
8.6*
17.1
10.9
8.4*
9.4
20.9
14.9
15.7*
15.1
1.43
10.8
7.5
10.6
6.7
9.1
9.1
6.5
1.3
7.5
3.0
6.6
S
20.2 ±
29.6 ±
25.4 ±
29.6
31.4 ±
25.8 ±
20.8 ±
12.2 ±
30.3 ±
26.4 ±
18.3 ±
32.7 ±
27.0 ±
17.8 ±
19.8 ±
31.8 ±
25.4 ±
23.8 ±
23.2 ±
22.3 ±
17.8 ±
26.7 ±
28.3 ±
18.6 ±
30.4 ±
25.5 ±
26 A ±
17.6 ±
16.7 ±
24.3 ±
30.3 ±
26.2 ±
33.2 ±
26.3 ±
32.4 ±
27.4 ±
30.2 ±
27.4 ±
32.4 ±
27.4 ±
1.8
1.7
3.2
1.4
1.1
0.1
0.4
4.1
2.9*
12.7
2.4
2.3
7.1
6.8
4.1
5.0
7.8
1.8
1.8*
0.9
6.0
1.1
9.4
11.6
6.4
4.8*
4.4
6.1*
1.5*
2.6
4.1
1.9
4.5
3.8
2.2
0.7
2.0
1.8
1.7
G,
12.9
15.8
17.9
13.6
15.6
14.9
18.7
16.4
15.7
24.6
12.2
14.0
15.5
14.7
14.9
10.7
21.7
16.5
14.0
19.5
12.6
17.5
25.1
11.4
14.3
13.6
20.6
21.6
24.4
32.5
20.1
16.9
18.2
17.9
18.0
17.1
23.8
21.3
20.9
19.0
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
7.8
2.3
5.0
5.5
3.3
5.7
15.1
4.7
3.4
6.5
4.7
2.7
3.4
13.7
6.4
9.6
16.0
8.2
7.4
16.2
15.2
7.3*
0
9.3
9.0
12.1
10.6
15.6
9.3
5.8
6.5
4.7
5.0
5.9
4.6
0.6
5.2
1.8
5.1
cvc,
3.3 ± 0.1
3.6 ± 0.6
3.1 ± 0.2
4.5
3.2 ± 0.3
3.8 ± 1.5
3.7 ± 1.2
3.6 ± 0.1*
3.5 ± 0.7
3.4 ± 0.1
4.0 ± 1.4
3.1 ± 0.4
3.9 ± 1.4*
2.9 ± 0.3
3.9 ± 0.3
4.4 ± 0.5*
3.8 ± 0.2
4.1 ± 1.6
4.8 ± 1.1
3.5 ± 0.4
4.0 ± 0.9
4.6 ± 0.7
3.8 ± 0.6
4.5 ± 1.2
3.8 ± 0.6
5.2 =fc 0.6
3.7 ± 0.2
4.0 ± 0.5
4.6 =fc 0.6
3.7 ± 0.6
3.7 ± 1.0
3.1 ± 0.4
4.2 ± 1.2*
3.7 ± 0.4*
3.9 ± 0.4
4.2 ± 1.0*
3.7 ± 0.1
4.0 ± 0.2
3.6 ± 0.5
4.3 ± 0.4*
Protein
CPGI
72 ± 6
74 ± 21
83 ± 16
73
72 ± 6
72 ± 17*
64 ± 12
75 ± 6
74 ± 24
80 ± 9
68 ± 8
76 ± 2*
76 ± 23
77 ± 5
78 ± 20
86 ± 21
92 ± 21
81 ± 6
89 ± 24*
91 ± 12*
71 ± 13
88 ± 16
88 ± 19
72 ± 13
84 ± 4.7*
92 ± 14*
101 ± 15*
71 ± 4
79 ± 24
90 ± 11
68 ± 7
69 ± 14
70 ± 14
76 ± 11
71 ± 9
74 ± II
66 ± 10
67 ± 1
72 ± 10
75 ± 13
wGI
1.47
1.39
1.38
1.33
1.37
1.40
1.42
1.50
1.42
1.44
1.32
1.44
1.40
1.38
1.51
1.57
1.46
1.44
1.47
1.53
1.53
1.50
1.47
1.33
1.42
1.51
1.54
1.49
1.51
1.63
1.39
1.34
1.39
1.35
1.34
1.34
1.35
1.35
1.36
1.32
± 0.01
± 0.09
± 0.03
± 0.07
± 0.08
±0.11
± 0.10
± 0.08*
± 0.01
± 0.03
± 0,06
± 0.10
± 0.09
± 0.01
± 0.14*
± 0.05*
± 0.10
± 0.07*
± 0.16
± 0.02
± 0.05
± 0.09
± 0.01
± 0.03
± 0.09
± 0.16
± 0.13
± 0.05
± 0.15
± 0.04
± 0.05
± 0.03
± 0.04
± 0.08
± 0.05
± 0.01
± 0.03
± 0.02
± 0.06
KP 7-cells
Control
1 nM
3.2 ILM
10 iM
32 ^M
100 ^M
Practolol
Control
I fiM
10 uM
100 ^M
320/xM
24
24
24
24
24
24
5
24
5
24
5
24
5
24
5
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
24
2
2
2
2
2
2
3
3
3
3
3
2
3
3
2
2
70.0
70.0
70.1
69.6
68.5
57.0
50.4
54.0
50.5
55.9
46.9
57.5
50.0
55.3
41.3
49.8
±
±
±
±
±
±
±
±
±
±
±
±
±
1.3
3.3
1.9
1.8
2.0
0.1
9.1
10.8
9.1
3.0
9.6
5.9
11.0
7.5
0.1
1.8
15.4
15.0
15.3
14.9
14.9
17.0
30.9
27.4
31.5
27.3
32.2
27.5
31.7
26.6
36.6
30.1
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
1.4
0.8
0.5
0.7
0.7
0.4
2.8
4.0
3.1
0.7
4.0
2.8
5.0
2.8
2.6
0.5
14.6 ±
15.0 ±
14.7 ±
15.4 ±
16.6 ±
26.0 ±
18.7 ±
18.5 ±
18.0 ±
16.8 ±
20.9 ±
15.0 ±
18.6 ±
18.1 ±
22.0 ±
20.1 ±
0.1
1.5
1.3
01.1
0.8
0.4
6.3
6.8
6.1
2.6
7.2
3.2
6.4
4.9
2.0
1.4
2.8
2.9
3.3
3.1
3.2
3.5
3.6
3.1
3.6
2.7
4.0
2.8
3.8
3.5
3.5
3.0
± 0.2
± 0.6
± 0.1
± 0.4
± 0.8
± 1.3
± 1.1
± 0.5
± 0.8
± 0.3
± 0.6
± 0.1
± 0.8
± 0.4
± 1.1
± 0.4
78 ±
81 ±
73 ±
68 ±
83 ±
76 ±
71 ±
66 ±
77 ±
68 ±
74 ±
73 ±
68 *
76 ±
84 ±
63 ±
20
18
27
25
40
23
4
6
23
8
22
9
14
13
15
5
1.38
1.36
1.37
1.35
1.33
1.37
1.40
1.35
1.34
1.34
1.36
1.36
1.34
1.36
1.34
1.39
± 0.08
± 0.01
± 0.08
± 0.01
± 0.07
± 0.02
± 0.05
± 0.06
± 0.03
± 0.05
± 0.04
± 0.08
± 0.02
± 0.04
± 0.04
± 0.01
mean ± SD.
n number of experiments.
* Significantly different from the control culture paired /-test (P > 0.05).
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Fig. 3. Drug-induced exposure-response effect of the DNA/protein parameter after treatment with doxorubicin and nitrofurantoin. Control values are set at
100%.
presence of the drug and providing sensitive targets for the
potential clastogenic activity of the two test agents. With both
drugs, the extension in the recovery period from 24 to 48 h re-
sulted in a slight decrease in the CV and protein values. Most
likely, after 24 h few additional damaged cells enter the cell cycle
to reach the G, phase and give rise to a viable aneuploid cells.
After 48 h the fraction of unaffected cells selectively increases.
With DX no abnormal position of the G) DNA peak was
detectable which could be attributed to the fluorescence of the
test compound itself.
Alterations in the cell cycle phases change dramatically
depending on the exposure/recovery intervals chosen and the drug
used (Figure 3). In all experimental protocols, DX accumulated
cells at G2/M phase with a feedback control to S phase. The
increase of S- and G2/M-phase cells induced by NF at the
5/24-h and 24/48-h schedule is probably caused by a release of
the cells from the chemically induced cytostatic blockage in the
G| phase. More cells then begin to divide and enter the S and
G2/M phases with a corresponding decrease in G] phase.
Clearly the effect of DX is longer lasting than that of NF.
With both chemicals the increase in cellular protein content
(CPGi) and in heterogeneity (WG1 values) is most efficiently
induced after a 24-h exposure/24-h recovery interval;
qualitatively, a 5/24-h schedule gives similar results. Exposure
of cells to nitrofurantoin under hyperoxic conditions (31 % O2)
or the shortening of the recovery period did not result in increased
activity of the chemical (Table HI).
With propranolol, no statistically significant dose-dependent
alterations in the cell cycle phase were detected, but an increase
in the CVG1 value at the 24/24-h schedule was noted. These
trends were more clearly apparent in experiments with human
fibroblasts. Here the drug reduced the contribution of G, phase
and increased the CVG, in a dose-dependent way: neither the
CPG, values nor the W values (Table III) were affected. With
practolol, no dose-dependent effect was detectable on any
parameter over the entire dose range tested.
Discussion
Binding of fluorochrome to DNA can be influenced by conforma-
tional changes in the heterochromatin-DNA complex and this
effect can be observed between different cell types in the same
animal. Reversible changes are also observed in normal dividing
cells in different phases of the cell cycle, e.g. between Go- and
G,-phase cells (Moser et at, 1981). These conformational
changes can be induced chemically, possibly by causing a shift
of cells from Go to G, phase (Moser and Maier, 1987). How-
ever, in continuous cultures in which cell-density-dependent
inhibition is achieved 96 h after seeding (Table II), G0-phase
cells accumulated but CVG1 did not increase significantly (Table
II). Even slightly decreased values derive from the absence of
cells just entering the S phase (CVG|) and from the absence of
cells in metaphase (CVG2). So far, no evidence exists to indi-
cate that with our protocols conformational changes in the
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Table IV.
Compound
Pattern of changes in the
Type of
interaction
DNA and protein histograms
Exposure
level
obtained by
DNA
G,
two-parameter
S
flow cytometry
G2
24 h after treatment
cvG I
Protein
CP W
Model compounds (5/24-h schedule; from Maier and Schawalder, 1986)
Bleomycin
Amethopterin
Vincristine
Test chemicals
Doxorubicin
Nitrofurantoin
Propranolol
Practolol
Clastogenic
DNA-synthesis
inhibiting
Spindle
poison
(24/24-h schedule)
Clastogenic
Cytostatic/
clastogenic
Spindle-
poison like
None
Low
High
Low
High
Low
High
Low
High
Low
High
Low
High
Human cells
Low
High
0
0
0
0
0
0
0
0
0
0
0
0
+
+ +
0
+
Characterization of dose—response curves: Each + and — represents an exposure level with value (mean) above 115% (+) or below 85% (—) of that of
untreated controls and this in the lower (low) or upper (high) exposure range tested.
( ) = trends to be observed.
DNA-chromatin complex contribute to enhanced CV values in
the rat cell population.
An attempt was made to classify the four chemicals according
to their effects upon the CVG,, cell cycle phase, CPG, and WG,
values (Table IV). Data from the previously tested model
compounds bleomycin, amethopterin and vincristine (Maier and
Schawalder, 1986) were used as standards. Classification was
based on the data obtained after a 24-h exposure/24-h recovery
period. Results obtained after a 48-h recovery period probably
reflected non-specific recovery phenomena in the cell population
rather than the drug-specific response of the cells to the initial
insult.
The pattern observed with DX (Tables III and IV) is consistent
with the known clastogenic activity of this chemical. G2-phase
blockage confirmed reports on the inhibitory activity of this drug
in late S phase (Silvestrini et al., 1970) and in G2 phase
(Wheatley, 1972). The doubling of the CVG1 values is in
agreement with the unusually high frequency of structural
chromosome aberrations found in vitro (Vig, 1971). The
concomitant increase in the protein content suggests that
uncoupling between protein and DNA synthesis might be typical
for chemicals which preferentially induce structural chromosome
aberrations. This alteration in the nucleus/cytoplasma ratio in
G(-phase cells was observed previously with bleomycin (Maier
and Schawalder, 1986). Protein synthesis proceeded independent-
ly of DNA synthesis and continued until the normal G2 phase
protein level was reached (Table II, Figure 3). The breakdown
of this drug-induced effect was seen at the highest exposure level
(0.1 jtg/ml). Typically, the DNA parameters are affected (S and
G2 phase and CVG), Table II) without evidence of cytotoxicity
(protein leakage).
From CV values obtained with NF, the drug appeared to be
metabolized to genotoxic intermediates in the fibroblast-like cells
of the granulation tissue. Activation of nitrofurans can occur via
the prostaglandin-synthetase pathway (Zenser et al., 1984). This
pathway is functional in the fibroblast-like cells used in the present
study (Lang et al., 1986). Prostaglandin synthesis is associated
with cell proliferation (Cornwell and Morisaki, 1984) and
initiation of DNA synthesis (Otto et al., 1982). It could well be
that NF induces, concomitant with the metabolic inhibition of
cell proliferation, chromosome aberrations in all cell cycle stages
without further progression and accumulation in one particular
cell cycle stage. From this synchronous arrest a rapid recovery
of non-damaged cells from the cytostatic activity is possible, as
suggested by data from cell cycle phases and CV analysis in the
5/24-h and 24/48-h schedules. We can thus postulate that the
combined cytostatic and clastogenic activity (CVG1 values) of
the chemical may prevent the progression of aneuploid cells. Such
a failure of progression of particular cell types may explain the
non-carcinogenic activity of NF (Morris et al., 1969, Yahagi et
al., 1974).
The pO2 does not seem to be critical for the metabolic con-
version of NF to mutagenic metabolites. The relatively high
effective exposure levels required indicate that in vivo this
chemical will most likely exert its mutagenic activity after direct
interaction with target tissues. In fact, when given intraperi-
toneally to rats, NF caused DNA strand breaks in liver (Russo
et al., 1982) but had no effect on micronuclei formation in bone
marrow cells (Goodman et al., 1977).
The pattern induced by propranolol in rat and human cells
resembles qualitatively that of a spindle poison (Table IV). This
could explain why no mutagenic activity was found in bacterial
tests while an increased formation of micronuclei in mouse bone
marrow was observed (Okine et al., 1983). At an exposure of
3/4 LD50 an increase of nearly 3-fold in the micronuclei
frequency, without interference with the proliferative capacity
of the bone marrow cells, was reported (Aruna and Krishna-
murthy, 1986). The activity found in our investigation with
human cells suggests that they metabolize propranolol more
efficiently than rodent cells (Elliott et al., 1984).
Quantitatively, the aneuploidy-inducing activity of propranolol
seems to be much weaker than with vinblastin. Differences in
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the incidence of chromosomal loss in post-mitotic cells between
different spindle poisons are well described. In the micronucleus
test, colchicine induces a much lower incidence of micronuclei
than the alkaloid vincristine (Maier and Schmid, 1976). This
difference in micronucleus-inducing capability could be a con-
sequence of the different binding sites of the two chemicals
(Dustin, 1984). It is interesting that propranolol exhibits tumour-
promoting activity for rat liver (Boyd and Martin, 1977) similar
to that of phenobarbital (PB). Also, PB has been reported to
interefere with tubulin assembly (Albertini et ai, 1985).
However, further data are needed from chemicals with well-
characterized interactions with individual steps in the chromo-
somal segregation process, in order to investigate the potential
correlation between flow data and the mechanisms involved.
In conclusion, the concomitant analysis of cellular protein and
DNA content in living Grphase cells by flow cytometry appears
to allow the detection of chemicals which induce numerical and
structural aberrations. In addition, the interaction with
chromosomal material can be characterized. In a tier approach
this information enables the efficient selection of the most suitable
additional mutagenicity test for confirmation or risk evaluation.
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